Pharma Q4 Results Preview: Shire, Bayer, Merck KGaA

 
• By Eleanor Malone, Lucie Ellis-Taitt, and Kevin Grogan
  
Changes ahead
Hemophilia market disruption and IO progress among challenges for final Q4 reporters • Source: Shutterstock

More from Earnings

More from Business